Mar 27, 2020 · View detailed financial information, real-time news, videos, quotes and analysis on Acceleron Pharma Inc. (NASDAQ:XLRN). Explore commentary on Acceleron Pharma Inc. and hear what the experts at Acceleron Pharma Inc : XLRN Stock Price Quote at Ally Invest Free current stock price quotes and data for Acceleron Pharma Inc (XLRN). Research news, charts, stock market performance and earnings. Quotes Snapshot > XLRN. Citigroup Cuts Acceleron Pharma Price Target to $136 From $138, Maintains Buy Rating 11:34AM ET 3/02/2020 MT Newswires. ACCELERON PHARMA INC. : XLRN Stock Price | MarketScreener
Acceleron Pharma Inc quote is equal to 86.660 USD at 2020-04-07. Based on our forecasts, a long-term increase is expected, the "XLRN" stock price prognosis for
Based on 11 analysts offering 12 month price targets for Acceleron Pharma in the last 3 months. The average price target is $110.10 with a high forecast of Acceleron Stock Is Skyrocketing After Surprise Drug-Trial Success. One analyst more than doubled his price target on the stock, but others say the boom may be a Their average twelve-month price target is $98.85, suggesting that the stock has a possible upside of 22.36%. The high price target for XLRN is $136.00 and the Analyzing Acceleron Pharma (NASDAQ:XLRN) stock? View XLRN's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings (See XLRN's stock analysis on TipRanks)The $109 average analyst price target translates into 35% upside potential from the current share price. Shares have
Acceleron Pharma (NASDAQ:XLRN) PT Raised to $129.00 at HC ...
Acceleron Pharma (NASDAQ:XLRN) PT Lowered to $128.00 at HC ... Acceleron Pharma (NASDAQ:XLRN) had its price objective reduced by HC Wainwright from $129.00 to $128.00 in a research note issued to investors on Tuesday morning, BenzingaRatingsTable reports. Ride Out The Next Market Storm With Acceleron Pharma Inc ... 13 days ago · The stock was given Buy rating by Citigroup in its report released on May 24, 2019, the day when the price target on the stock was placed at 66. Barclays was of a view that XLRN is Equal Weight in its latest report on May 03, 2019. Oppenheimer thinks that XLRN is worth Outperform rating. Acceleron Pharma (NASDAQ:XLRN) Price Target Increased to ...
23 Biotechnology Stocks Moving In Monday's After-Market ...
Acceleron Pharma Inc. Stock Price (XLRN) | Barron's View today's stock price, news and analysis for Acceleron Pharma Inc. (XLRN). Barron's also provides information on historical stock ratings, target … XLRN | Acceleron Pharma Inc. Analyst Estimates | MarketWatch Nov 04, 2019 · Acceleron Pharma Inc. analyst estimates by MarketWatch. View XLRN revenue estimates and earnings estimates, as well as analyst recommendations. XLRN | Acceleron Pharma Inc. Analyst Estimates & Rating – WSJ
Acceleron Pharma Inc. - NASDAQ:XLRN - Stock Quote & News ...
28 Jan 2020 Some analysts say the compound has blockbuster potential. Acceleron's closing stock price Tuesday was $79.39, up more than 50 percent 28 Jan 2020 Piper Sandler analyst Danielle Brill reiterates an Overweight rating on Acceleron shares. 2020年1月28日 drug is sending shares of the biotech firm Acceleron Pharma soaring. One analyst more than doubled his price target on the stock, but others 6 days ago The shares of Acceleron Pharma Inc. (NASDAQ:XLRN) has been pegged Amongst the analysts that rated the stock, 0 have recommended